Please provide your email address to receive an email when new articles are posted on . Intraocular lens surgery was once seen as a last resort for patients interested in spectacle independence, but ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...
In March 2022, the U.S. Food and Drug Administration (FDA) granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism. Myopia is ...
Please provide your email address to receive an email when new articles are posted on . Using vertical fixation for implantable collamer lens placement may improve clinical outcomes, according to a ...
LAKE FOREST, Calif. & INDIANAPOLIS--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the ...
The U.S. Food and Drug Administration (FDA) on Tuesday approved an expanded age indication for Staar Surgical Company’s STAA EVO/EVO+ Visian Implantable Collamer Lenses (ICL). The stock is trading ...
ICL surgery (also known as EVO Implantable Collamer or Interocular Contact Lens) is an alternative to Lasik. During the procedure, an eye surgeon who is specially trainedimplants contact lenses ...
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that more than 4 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results